S. Lindsey Davis - Concepedia

Author

S. Lindsey Davis

Johns Hopkins University ORCID

Also Known As

S Davis, S. Davis, S. L. Davis, S. Lindsey Davis, S.Lindsey Davis, Stephanie Davis, Stephanie L. Davis

Publications

900

Citations

H-Index

Concepts

All Affiliations

Johns Hopkins University Johns Hopkins Medicine Bloomberg (United States)Sidney Kimmel Comprehensive Cancer Center University of Colorado Denver

About

S. Lindsey Davis is an author at Johns Hopkins University.

S. Lindsey Davis

Publications

858

Citations

H-Index

Page 1

	Year	Citations
Mouse Model of Necrotic Tuberculosis Granulomas Develops Hypoxic Lesions Jamie Harper, Ciaran Skerry, S. Lindsey Davis, The Journal of Infectious Diseases	2011	260
Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenografts Anna Capasso, Julie Lang, Todd M. Pitts, Journal for ImmunoTherapy of Cancer	2019	166
Noninvasive Pulmonary [ <sup>18</sup> F]-2-Fluoro-Deoxy- <scp>d</scp> -Glucose Positron Emission Tomography Correlates with Bactericidal Activity of Tuberculosis Drug Treatment S. Lindsey Davis, Eric Nuermberger, Peter Um, Antimicrobial Agents and Chemotherapy	2009	135
Sulforaphane exhibits antiviral activity against pandemic SARS-CoV-2 and seasonal HCoV-OC43 coronaviruses in vitro and in mice Alvaro A. Ordoñez, C. Korin Bullen, A.F. Villabona-Rueda, Communications Biology	2022	79
Bacterial Thymidine Kinase as a Non-Invasive Imaging Reporter for Mycobacterium tuberculosis in Live Animals S. Lindsey Davis, Nicholas A. Be, Gyanu Lamichhane, PLoS ONE	2009	65
Phase Ib Results of the Rational Combination of Selumetinib and Cyclosporin A in Advanced Solid Tumors with an Expansion Cohort in Metastatic Colorectal Cancer Anuradha Krishnamurthy, Arvind Dasari, Anne M. Noonan, Cancer Research	2018	30
Association of Cancer Immunotherapy With Acute Macular Neuroretinopathy and Diffuse Retinal Venulitis Leisha A. Emens, S. Lindsey Davis, Scott C. N. Oliver, JAMA Ophthalmology	2018	28
Quantification of Infectious SARS-CoV-2 by the 50% Tissue Culture Infectious Dose Endpoint Dilution Assay C. Korin Bullen, S. Lindsey Davis, Monika M. Looney Methods in molecular biology	2022	28
Intravenous BCG vaccination reduces SARS-CoV-2 severity and promotes extensive reprogramming of lung immune cells Alok Kumar Singh, Rulin Wang, Kara A. Lombardo, iScience	2023	23
Sulforaphane exhibits in vitro and in vivo antiviral activity against pandemic SARS-CoV-2 and seasonal HCoV-OC43 coronaviruses Alvaro A. Ordoñez, C. Korin Bullen, A.F. Villabona-Rueda,	2021	19

Page 1